Journal for ImmunoTherapy of Cancer · 2026-05-28
CLEC2B-KLRB1 axis acts as an immune checkpoint, governing the exhaustion of CD8+ T cells and their resistance to immune checkpoint blockade
Phrase rank #1 · DOI 10.1136/jitc-2025-013637
Other observed topics
immune checkpoint
Observed in 158 articles across 16 journals.
Latest share0.13%
Change vs baseline-0.22 pp
Months observed13
Latest monthJul 2026
Portfolio article share
Attention over this snapshot
13 monthly points
Journal breadth
Where it appears
- Journal for ImmunoTherapy of Cancer119
- BMJ Case Reports9
- Journal of Neurology, Neurosurgery & Psychiatry4
- BMJ Open3
- European Journal of Hospital Pharmacy3
- Frontline Gastroenterology3
- Gut3
- Heart3
- Thorax3
- BMJ Oncology2
- BMJ Immunology1
- Journal of Clinical Pathology1
Co-occurrence
Explore nearby topics
Inspect the source signal
Article evidence
30 high-ranking examples
Practical Neurology · 2026-05-14
Immune checkpoint inhibitor-associated bilateral optic neuritis
Phrase rank #1 · DOI 10.1136/pn-2025-004640
Journal for ImmunoTherapy of Cancer · 2025-11-04
885 Intratumoral administration of VAX014 induces tertiary lymphoid structure formation
Phrase rank #1 · DOI 10.1136/jitc-2025-SITC2025.0885
Journal for ImmunoTherapy of Cancer · 2025-11-04
560 Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in bilateral lung transplantation: case series
Phrase rank #1 · DOI 10.1136/jitc-2025-SITC2025.0560
BMJ Immunology · 2026-06-05
Tolerance–resistance continuum in immune checkpoint pathways: molecular architecture, spatial niches and clinical consequences
Phrase rank #2 · DOI 10.1136/bmjimm-2025-000010
Journal for ImmunoTherapy of Cancer · 2026-03-27
Pharmacologic targeting of the dopamine D2 receptor impacts the efficacy of immune checkpoint blockade in melanoma
Phrase rank #2 · DOI 10.1136/jitc-2025-014080
European Journal of Hospital Pharmacy · 2026-03-18
5PSQ-089 Impact of proton pump inhibitor exposure on progression-free and overall survival in patients treated with immune checkpoint inhibitors
Phrase rank #2 · DOI 10.1136/ejhpharm-2026-eahp.515
Journal of Neurology, Neurosurgery & Psychiatry · 2025-11-26
229 Immune checkpoint inhibitors and neurological toxicity: a UK case series
Phrase rank #2 · DOI 10.1136/jnnp-2025-ABN.229
Journal for ImmunoTherapy of Cancer · 2025-11-04
477 Association of baseline medication exposure with real-world overall survival in patients with cancer treated with immune checkpoint inhibitors in the RADIOHEAD cohort
Phrase rank #2 · DOI 10.1136/jitc-2025-SITC2025.0477
Journal for ImmunoTherapy of Cancer · 2025-11-04
1075 Case series of pancreatitis from immune checkpoint inhibitors mimicking pancreatic malignancy
Phrase rank #2 · DOI 10.1136/jitc-2025-SITC2025.1075
Journal for ImmunoTherapy of Cancer · 2025-11-04
404 Use of immune checkpoint inhibitors in patients with a prior history of neurologic autoimmune disease: a retrospective cohort study
Phrase rank #2 · DOI 10.1136/jitc-2025-SITC2025.0404
Journal for ImmunoTherapy of Cancer · 2025-11-04
927 Enhanced survival with immune checkpoint inhibitors across tumor histologies during the COVID-19 pandemic is strongly associated with SARS-COV-2 mRNA vaccination
Phrase rank #2 · DOI 10.1136/jitc-2025-SITC2025.0927
Journal for ImmunoTherapy of Cancer · 2025-11-04
516 An open-label, phase II multicenter study of rituximab or tocilizumab for steroid-dependent or steroid-refractory immune-related adverse events due to immune checkpoint inhibitors
Phrase rank #2 · DOI 10.1136/jitc-2025-SITC2025.0516
Journal for ImmunoTherapy of Cancer · 2025-10-29
PD-L1 directed bispecific Vδ2-T cell engager combines lysis of PD-L1 expressing tumor cells with PD-1 immune checkpoint inhibition and modulation of the tumor immune microenvironment
Phrase rank #2 · DOI 10.1136/jitc-2025-012255
Journal for ImmunoTherapy of Cancer · 2025-10-29
Acetaminophen interactions with immune checkpoint inhibitors: guilt by association?
Phrase rank #2 · DOI 10.1136/jitc-2025-012355
Frontline Gastroenterology · 2025-08-10
Iatrogenic effect of immune checkpoint inhibitors and targeted therapies on the lower gastrointestinal tract
Phrase rank #2 · DOI 10.1136/flgastro-2025-103094
Gut · 2026-06-23
P211 Infection risk and clinical outcomes in immune checkpoint inhibitor–induced colitis
Phrase rank #3 · DOI 10.1136/gutjnl-2026-BSG.334
Frontline Gastroenterology · 2026-06-17
Faecal calprotectin predicts corticosteroid non-responsiveness in patients with immune checkpoint inhibitor colitis
Phrase rank #3 · DOI 10.1136/flgastro-2026-103663
Journal of Scleroderma and Related Disorders · 2026-06-05
P.194 Raynaud’s phenomenon in the setting of immune checkpoint inhibitors: a case series and possible implications
Phrase rank #3 · DOI 10.1136/JSRD-2026-SSWC.238
Gut · 2026-05-12
Targeting MLCK1 uncouples immune checkpoint inhibitor-induced colitis from antitumour immunity
Phrase rank #3 · DOI 10.1136/gutjnl-2025-337780
BMJ Open · 2026-03-03
Pragmatic, open-label, multicentre, randomised controlled trial to guide initial therapy for immune checkpoint inhibitor-induced inflammatory arthritis comparing standard of care (prednisolone) to adalimumab without glucocorticoids: REACT trial protocol
Phrase rank #3 · DOI 10.1136/bmjopen-2026-116847
Journal for ImmunoTherapy of Cancer · 2026-02-04
Synergistic effects of anticoagulants and platelet aggregation inhibitors with immune checkpoint inhibitors in cancer therapy: a comprehensive review of preclinical and clinical evidence
Phrase rank #3 · DOI 10.1136/jitc-2025-013879
BMJ Case Reports · 2026-01-28
Use of intravenous immunoglobulin in combination with corticosteroids for immune checkpoint inhibitor pneumonitis
Phrase rank #3 · DOI 10.1136/bcr-2025-270094
BMJ Oncology · 2025-11-24
Incidence of fractures in patients with solid cancers treated with immune checkpoint inhibitors: a systematic review and meta-analysis of randomised controlled trials
Phrase rank #3 · DOI 10.1136/bmjonc-2025-000868
Journal for ImmunoTherapy of Cancer · 2025-11-04
157 A novel multi-omic algorithm to predict real-world outcomes among patients with rare, advanced, solid cancers treated with off-label immune checkpoint inhibitors
Phrase rank #3 · DOI 10.1136/jitc-2025-SITC2025.0157
Journal for ImmunoTherapy of Cancer · 2025-11-04
187 CD96: a new predictor of poor prognosis in advanced human gliomas
Phrase rank #3 · DOI 10.1136/jitc-2025-SITC2025.0187
Journal for ImmunoTherapy of Cancer · 2025-11-04
1059 Immune checkpoint inhibitors, irAE, and treatment patterns in patients with melanoma: a single center experience
Phrase rank #3 · DOI 10.1136/jitc-2025-SITC2025.1059
Journal for ImmunoTherapy of Cancer · 2025-11-04
1078 Age-associated outcomes in triple-negative breast cancer patients treated with immune checkpoint inhibitors: a real-world analysis of toxicity and survival in adults <70 vs ≥70 years
Phrase rank #3 · DOI 10.1136/jitc-2025-SITC2025.1078
Journal for ImmunoTherapy of Cancer · 2025-11-04
1071 SGLT2 inhibitor use and survival in solid tumors treated with immune checkpoint inhibitors: a real-world cohort study
Phrase rank #3 · DOI 10.1136/jitc-2025-SITC2025.1071
Journal for ImmunoTherapy of Cancer · 2025-09-23
Immune-related adverse events occurring rapidly after a single dose of immune checkpoint blockade
Phrase rank #3 · DOI 10.1136/jitc-2025-012756